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Background: Drugs used both in classical chemotherapy and the more recent targeted therapy do not have
cancer cell specificity and, hence, cause severe systemic side effects. Tumors also develop resistance to such drugs
due to heterogeneity of cell types and clonal selection. Several traditional dietary ingredients from plants, on the
other hand, have been shown to act on multiple targets/pathways, and may overcome drug resistance. The dietary
agents are safe and readily available. However, application of plant components for cancer treatment/prevention
requires better understanding of anticancer functions and elucidation of their mechanisms of action. The current
study focuses on the anticancer properties of fenugreek, a herb with proven anti-diabetic, antitumor and
immune-stimulating functions.
Method: Jurkat cells were incubated with 30 to 1500 μg/mL concentrations of 50% ethanolic extract of dry
fenugreek seeds and were followed for changes in viability (trypan blue assay), morphology (microscopic
examination) and autophagic marker LC3 transcript level (RT-PCR).
Results: Incubation of Jurkat cells with fenugreek extract at concentrations ranging from 30 to 1500 μg/mL for up
to 3 days resulted in cell death in a dose- and time-dependent manner. Jurkat cell death was preceded by the
appearance of multiple large vacuoles, which coincided with transcriptional up-regulation of LC3. GC-MS analysis of
fenugreek extract indicated the presence of several compounds with anticancer properties, including gingerol
(4.82%), cedrene (2.91%), zingerone (16.5%), vanillin (1.52%) and eugenol (1.25%).
Conclusions: Distinct morphological changes involving appearance of large vacuoles, membrane disintegration
and increased expression of LC3 transcripts indicated that fenugreek extract induced autophagy and
autophagy-associated death of Jurkat cells. In addition to the already known apoptotic activation, induction of
autophagy may be an additional mechanism underlying the anticancer properties of fenugreek. This is the first
report showing fenugreek as an inducer of autophagy in human cells and further work is needed to define the
various intermediates of the autophagic pathway.
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Currently used drugs in cancer treatment cause severe
side effects, since the targeted pathways also occur
in rapidly dividing normal cells [1]. Newly emerging
targeted drugs rely on inhibiting an aberrant tumor-
promoting pathway and the heterogeneity of cell types* Correspondence: aldaghri2011@gmail.com
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reproduction in any medium, provided the orenable cancers develop drug resistance [2]. In addition,
genetic instability enables malignant cells to evade in-
hibitor drugs by secondary mutations in target genes
and other genetic changes [2]. As a consequence,
progress has been lacking in treating the majority
of cancers.
Plant constituents and derivatives hold great promise
for cancer prevention and treatment [3-5]. It is now
believed that majority of cancers are attributed to envir-
onmental and dietary factors and incorporating fruits,
vegetables, whole grains and spices in the diet seem toral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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plant components exhibit superior anticancer properties
by overcoming limitations of chemo- and targeted-
therapies. Several plant compounds used in traditional
medicine are common dietary ingredients and, hence,
are considered safe [10]. Plant-derived anticancer
agents are broad specific and affect multiple pathways
simultaneously. Some plant constituents inhibit tumor-
promoting pathways while also activating tumor-
suppressor pathways [11,12]. Plant-derived agents have
been effective at reducing inflammation and the level of
reactive oxygen species (ROS), both common hallmarks
of the genesis and progression of all cancers [13,14].
Certain plant components capable of killing cancer cells
are also known to suppress the tumor promoting actions
of immune and other tumor stromal cells [15]. In
addition, plant products are less expensive and readily
available. Intense research in this area has lead to mul-
tiple ongoing clinical trials involving plant derivatives
while a few have already been approved for human
use [16-18].
Fenugreek is commonly used as a traditional dietary
ingredient in India and Egypt, among others. As a medi-
cinal herb it has proven activity against hepatotoxicity
[19], diabetes [20,21], hyperlipidemia [22] and cardiovas-
cular diseases [19,23,24]. Fenugreek has anticancer prop-
erties [25] and has proven to be effective in preventing
colon [26] and breast cancers [27]. Fenugreek extract
also showed stimulatory effect on immune functions of
mice [28].
More research on underlying molecular mechanism
of the anticancer activity of fenugreek may lead to its
development as an effective therapeutic/chemopreventive
agent against various cancers. In this in vitro study we
show, for the first time, that fenugreek causes death of
T-lymphoma Jurkat cells by inducing autophagy.
Materials
The cell culture medium (RPMI-1640), fetal bovine
serum (FBS) and penicillin-streptomycin were purchased
from Gibco-BRL Life Technologies Inc. Jurkat cell line
was obtained from American Type Culture Collection
(ATCC), USA. Dry seeds of fenugreek, fennel, black pep-
per, coriander and cumin and sticks of cinnamon used
in this study were of food grade and obtained from com-
mercial sellers in Riyadh.
Methods
Preparation of spice extracts
1.5 g of each of the finely ground spices was suspended
in 50% ethanol in tightly capped bottles and shaken
overnight in water bath maintained at 40°C. The spice
suspensions were filtered and the filtrates evaporated
under N2 and the dry residues resuspended in 1.5 mL of50% ethanol to obtain stock solutions of 1 g/1 mL. Fur-
ther dilutions of fenugreek extract were made by mixing
with RPMI medium. Stock solution of fenugreek extract
was directly used for GC-MS.
Cell culture
The Jurkat cell line was cultured in RPMI-1640 med-
ium supplemented with FBS (10%, v/v), streptomycin
(100 μg/mL) and penicillin (100 U/mL). 5 X 104 cells/mL
were distributed into 24 well plates (1 mL/well) and incu-
bated under 5% CO2 in a humidified atmosphere at 37°C.
Cell viability assay
Cell numbers and viabilities were assessed using a
hemocytometer based on the ability of the viable cells to
exclude trypan blue. Briefly, at the end of treatment
period cells in the wells were mixed well and an aliquot
of cells were mixed with an equal volume of 0.4% trypan
blue and after 2-3 minutes viable cells were counted by
hemocytometer. Viable cells were expressed as a per-
centage of cells in the untreated well, which at the end
of the incubation period was considered 100%. Cell
numbers with standard error were averaged from 3 inde-
pendent experiments.
Morphological evaluation of cells
Normal and fenugreek extract treated cells were photo-
graphed using inverted light microscope at a magnifi-
cation of 400x.
Quantification of autophagy associated genes expression
by RT-PCR
Total RNA was isolated from Jurkat cells using Qiagen
RNeasy mini kit (Qiagen). RNA was reverse transcribed
into cDNA using QuantiTect Reverse Transcription Kit
(Qiagen). qRT-PCR was performed using SYBR Green
PCR kit (Qiagen). Primers used for RT-PCR are shown
in Additional file 1: Table S1. The master mixes were
pipetted into a 96-well plate followed by the addition of
40 ng of RNA. All samples were analyzed in triplicate.
PCR was run using the Bio-Rad Real-Time PCR System
which was programmed as follows: (1) 95°C stage for
10 minutes, and (3) 40 cycles alternating between 95°C
for 15 seconds and 60°C for 1 minute. Results were
analyzed by comparative Ct method using the formula:
2-ΔΔCT. ΔCT= CT value of gene of interest minus CT
value of β-actin. The ΔΔCT was calculated by subtract-
ing the ΔCT of the untreated cells from the ΔCT of the
test sample.
Gas chromatography–Mass spectrometry (GC-MS) analysis
GC/MS analysis of fenugreek extract was performed
using an Agilent 7890 GC System Gas Chromatograph
interfaced to a Mass Spectrometer (GC/MS) equipped
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0.25 μm). GC/MS detection was achieved using an elec-
tron ionization system with 70 eV ionization energy. He-
lium (99.999%) was used as carrier gas at a constant
flow rate of 1 mL/min. An injection volume of 2 μL was
employed in splitless mode. Injector and ion-source
were maintained at 250°C and 280°C, respectively. The
oven temperature was raised from 100°C (isothermal for
2 min.) to 200°C at a rate of 5°C/min and further
up to 240°C by 10°C/min and maintained at 240°C
for 11 min. Total GC running time was 40 minutes. The
relative amount of each constituent was calculated
by measuring corresponding peak area and represented
as a percentage of the sum of areas of all peaks. MS
Workstation 7.0 software was used to analyze mass
spectra and chromatograms.
Statistical analysis
Data was analyzed using the Microsoft Excel (Microsoft
Office 2007). Variables were presented as percentages (%).
Results
Screening spices for cytotoxicity against Jurkat cells
Jurkat cells were incubated with 50% ethanolic extracts
of 6 different spices at 1 mg/mL for 72 hr and viable
cells counted at the end by trypan blue exclusion assay
(Figure 1). Cinnamon and fenugreek treatment resulted
in death of 100% and 99% of cells, respectively. Only
25% viable cells were found after cumin treatment. Gin-
ger, black pepper and fennel extracts showed no effect
on the viability of Jurkat cells. Due to the distinct mor-
phological changes induced by fenugreek extract it was
chosen for further studies.Figure 1 Effect of different spice extracts on viability of Jurkat cells. J
different spices for 72 hr. Viable cells were counted by trypan blue assay as
cytotoxic and affected the viability of most of the cells.Effect of fenugreek extract on the viability of Jurkat cells
Jurkat cells were incubated with 30 to 1500 μg/mL of
fenugreek extract for 48 hr and viable cells counted at
the end. Percentage of viable cells showed a steady de-
crease with increasing concentrations of fenugreek
(Figure 2A). Cell death was observed even at 30 μg/mL
and most of the cells were lost at 1500 μg/mL. Jurkat
cells incubated with 250, 500 and 1000 μg/mL con-
centrations of fenugreek extract for up to 72 hr indi-
cated dose and time dependent decrease in viability
(Figure 2B). In this period, untreated cells almost
doubled in number in a day for 2 days and continued to
grow significantly on the 3rd day. At all the three con-
centrations of fenugreek most of the cells were lost
at 72 hr. Decrease in viable cells caused by fenugreek
extract was not matched by a corresponding increase
in dead cells by the trypan blue assay and this may be
due to the complete disintegration of plasma membrane
as shown in the following sections.
Morphological changes induced by fenugreek in
Jurkat cells
Incubation of Jurkat cells with fenugreek extract resulted
in the appearance of vacuoles at all concentrations of
fenugreek tested (Figure 3A). These vacuoles were large
enough to be seen directly by light microscope. Vacuoles
appeared from as early as 16 hr of incubation of cells
with higher concentrations of fenugreek (>250 μg/mL).
Some cells had a single large vacuole occupying most
of the cell space and others had more. The vacuoles
appeared highly spherical (Figure 3B). Appearance
of multiple large vacuoles was followed by disintegra-
tion of plasma membrane (Figure 4). With increasingurkat cells were incubated with 1mg/mL of 50% ethanolic extracts of
described in methods. Fenugreek and cinnamon extracts were highly
Figure 2 Fenugreek extract inhibits Jurkat cell proliferation. (A) Viability of Jurkat cells incubated with 30 to 1500 μg/mL of fenugreek extract
was determined after 48 hr by trypan blue assay. Death of Jurkat cells occurred at all the tested concentrations of fenugreek and followed a
dose-dependent pattern. (B) Time-dependent increase in death of Jurkat cells upon incubation with various concentrations of fenugreek.
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could be seen in the absence of distinct plasma mem-
brane and even these cytoplasmic cell structures disap-
peared over time, indicating complete cell lysis. Whole
cell lysis was also indicated by the absence of dead cells
upon staining with trypan blue even through the number
of viable cells showed large declines.
Fenugreek extract induced up-regulation of LC3
Jurkat cells were incubated with 250, 500 and 1000 μg/mL
concentrations of fenugreek extract for 24 and 48 hr.
RT-PCR analysis of RNA from these cells indicated up-
regulation of LC3 relative to β-actin in samples harvested
at 48 hr and the increase depended on the concentration
of fenugreek (Figure 5). A 2.5 fold increase in LC3 tran-
script was found in cells treated with 1000 μg/mL of
fenugreek compared to untreated cells. However, the
quantity of LC3 transcripts did not differ much from the
control at the end of 24 hr.GC-MS analysis of fenugreek extract
GC-MS analysis of fenugreek extract resolved into
34 peaks corresponding to a similar number of unique
compounds. Gingerol (4.82% of the total), cedrene
(2.91%), zingerone (16.5%), vanillin (1.52%), β-bisabolene
(1.25%) and eugenol (1.25%) were some of the anti-
cancer compounds identified by GC-MS in this extract
(Table 1).
Discussion
Plant derivatives have great promise as anticancer
agents. In this study, low concentrations of fenugreek
extract was found to induce death of Jurkat cells, a com-
monly used cell line model to understand anticancer
functions and underlying mechanisms of exploratory
drugs or compounds. Fenugreek extract affected the
viability of Jurkat cells in a dose- and time-dependent
manner. Fenugreek extract-induced death was pre-
ceded by dramatic morphological changes involving the
Figure 3 Fenugreek extract induced vacuoles in Jurkat cells. Overnight incubation of Jurkat cells with 1 mg/mL of fenugreek extract induced
distinct vacuoles. (A) The number of vacuoles range from 1 to several per cell. Arrow points to multiple vacuoles in a cell. (B) Arrows point to
Jurkat cells possessing two large spherical vacuoles. Pictures represent inverted light microscopic images taken at 400x magnification.
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up-regulation of LC3, both of which imply activation of
autophagy. Results from this study imply autophagy as a
novel mechanism by which fenugreek may bring about
death of preneoplastic/neoplastic cells. T-cell lymphoid
malignancies are a group of highly aggressive diseases that
are generally resistant to current treatment modalities
and results from this study indicate benefits of fenugreek
as a potential therapeutic. Further, induction of autoph-
agy may be a general anticancer mechanism underlying
chemopreventive/therapeutic function of fenugreek.
Anticancer properties of fenugreek or its constituents
involve multiple functional and molecular targets. Fenu-
greek induced apoptosis in a wide variety of tumor cell
lines, including those of human colon [26], osteosar-
coma [29], leukemia [30], breast [31,32], and liver [33].
Fenugreek blocked migration and invasion by reducing
matrix metalloproteinase expression in human prostateFigure 4 Fenugreek extract induced plasma membrane rupture and t
48 hr caused morphological changes leading to cell death. Disappearance
concentrations of fenugreek extract. Arrows point to cellular membranes u
images taken at 400x magnification.cancer PC-3 cells [34], decreased nitric oxide (NO) and
prostaglandin production by suppressing iNOS and
COX-2, respectively, in an osteosarcoma cell line [35].
Fenugreek blocked activation of NF-KB, I kappa B kin-
ase and AKT and suppressed the production of various
proinflammatory cytokines like IL-6, IL-1 and TNF-α by
cancer cells [31,36]. An earlier study noted the forma-
tion of cytoplasmic vacuoles in breast tumor tissue of 7,
12-dimethylbenz (α) anthracene (DBMA) treated rats
upon feeding of fenugreek compared to control [27]. To
our knowledge, ours is the first report to show death of
human cancer cells by fenugreek-induced autophagy.
Apoptosis and autophagy are important pathways
designed to cause programmed death of stressed cells
and cancers suppress both these pathways and evade
death. Autophagy has been defined as a process of
transport of cytoplasmic contents to the lysozomes in
double membrane compartments, called vacuoles [37].otal cell lysis. Increasing concentrations of fenugreek extract after
of cell shape by rupture of plasma membrane was seen at higher
ndergoing rupture. Pictures represent inverted light microscopic
Figure 5 Transcriptional regulation of autophagic genes by fenugreek. Jurkat cells incubated with 250, 500 and 1000 μg/mL of fenugreek
extract were quantitatively analyzed for transcripts of autophagic pathway genes beclin 1, ATG5 and LC3 by RT-PCR using β-actin as internal
reference. Dose dependent increase in LC3 transcripts was found in cells incubated for 48 hr while no significant changes were observed for
beclin 1 and ATG5.
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been suggested to enable cells to adapt and survive and,
hence, is considered a pro-survival mechanism [38].
Autophagy has also been defined as a highly conserved
process of programmed cell death [39] and its activation
causes cell death [40]. Defective regulation of autophagy
in cancers suggests that autophagy is a true tumor-
suppressor pathway [41,42] and this is further supported
by the fact that several commonly activated oncogenes
(for example, those encoding PI3K, TOR, Bcl-2) inhibit
autophagy, whereas commonly mutated or epigenetically
silenced tumor suppressor genes (such as those encod-
ing p53, PTEN, TSC1/TSC2) stimulate autophagy [43].
Several studies have used electron microscopic meth-
ods to detect autophagic vacuoles. However, fenugreek-
induced vacuoles in Jurkat cells were large and distinct
and could be directly seen using an inverted light





Formula % of Tota
8.54 4-Vinylguaiacol C9H10O2 1.36
9.452 Eugenol C10H12O2 1.25
10.463 Vanillin C8H8O3 1.52
13.05 β-Bisabolene C15H24 1.25
13.488 Cedrene C15H24 2.91
16.486 Zingerone C11H14O3 12.03
29.508 Gingerol C17H26O4 4.82
*Source of anticancer functions of fenugreek constituents: Dr. Duke's phytochemicaas an autophagic process from the transcriptional up-
regulation LC3. LC3 plays a critical role in autophagy and
is considered suitable marker of this process [44]. In the
present study, fenugreek extract increased LC3 transcript
level with increasing concentrations of fenugreek extract
over a period of 48 h. Harmol, a beta carotenoid, induced
death of lung cancer cells A549 was associated with
increased expression of LC3 [45] and siRNA knockdown
of LC3 resulted in blockade of cell death, which, in turn,
served to prove that harmol-induced autophagy was only
a death mechanism [45]. Transcripts of beclin 1 and
ATG5, the other autophagic pathway genes, did not show
any decline in our fenugreek-treated Jurkat cells and this
was similar to harmol-treated A549 cells which failed to
show any changes in the expression and phosphorylation
of beclin 1 [45].
Some health benefits of various medicinal plants or
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Antiemetic; anti-hepatotoxic; antihistaminic; anti-inflammatory;
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l and ethnobotanical databases (online database).
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performed to measure the autophagy-inducing ability of
several plant constituents, for eg., fisetin (found in toma-
toes, apples, onions, and grapes), genistein (soybean)
and quercetin (apple skins and red onions), report
opposing findings (induction or suppression) resulting in
reduced clarity on the beneficial effect of autophagy in
cancer treatment. These contradictory results have been
attributed to several factors, such as different methods
employed to measure autophagy and the use of different
cell types, such as cancerous cells versus normal cells
[46]. Also, autophagy, at low levels, was suggested to
serve a pro-survival role in tumors [47]. However, results
from our study revealed increased production of autop-
hagic markers and decreased viability to be associated
with increasing concentrations of fenugreek implying
only an anti-proliferative /pro-death function for autop-
hagy at all concentrations of fenugreek extract. Results
from our study support the notion that fenugreek-
induced autophagy in Jurkat cells could only be an anti-
tumor function.
Some of the components of fenugreek extract identi-
fied by GC-MS in our study have already been shown to
possess significant anticancer activities and these include
gingerol [14], cedrene [48], zingerone [49], vanillin [50],
and eugenol [51-53]. Future studies will be designed to
identify the specific compound(s) responsible for induc-
tion autophagy.
The cytotoxic effects of fenugreek are limited,
mostly, to cancer cells [25,32]. Bioavailability of thera-
peutic components of fenugreek, unlike curcumin, is
high as seen from its hepatoprotective effect from vari-
ous in vivo studies [54,55]. Feeding studies have indi-
cated tolerance and absence of any toxicities of up to
several grams of fenugreek per day over several weeks
[56].
The authors acknowledge some limitations. The study
included a limited type and number of cell lines and
lacked specific assays to confirm apoptosis and autop-
hagy. Nevertheless, the present study identified autop-
hagy as a new mechanism by which fenugreek may exert
its therapeutic/chemoprevention/anticancer function.Conclusion
Fenugreek induced autophagy in Jurkat cells in a time
and dose dependent manner, as indicated by morpho-
logical changes and up-regulated LC3. GC-MS analysis
of the fenugreek extract identified several compounds
having anticancer properties. Thus, due to its ability
induce death of Jurkat cells by autophagy at low concen-
trations and lower level of non-specific toxicity, fenu-
greek may serve as a potential therapeutic in the
treatment of lymphoid malignancy.Additional file
Additional file 1: Table S1. Primers used for analysis of expression of
autophagy associated genes by RT-PCR.
Competing interests
The authors have no competing interests to declare.
Authors’ contributions
SK and OEA performed cell culture experiments. AKM conducted RT-PCR
quantifications. SHA and SMY were involved in preparation of spice extracts
and GC-MS analysis. SK, MSA and KMA designed the experiments and
helped to draft the manuscript. NMD conceived and coordinated the study.
All the authors have read and approved the final manuscript.
Acknowledgements
The authors are grateful for the Prince Mutaib Chair for Osteoporosis
Research, King Saud University for funding and technical assistance.
Author details
1Biomarkers Research Program, Department of Biochemistry, College of
Science King Saud University, PO Box 2455, Riyadh 11451, Saudi Arabia.
2Prince Mutaib Chair for Osteoporosis Research, College of Science, King
Saud University, Riyadh 11451, Saudi Arabia. 3Department of Clinical
Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi
Arabia.
Received: 5 May 2012 Accepted: 16 October 2012
Published: 30 October 2012
References
1. Gibbs JB: Mechanism-based target identification and drug discovery in
cancer research. Science 2000, 287(5460):1969–1973.
2. Richardson ME, Siemann DW: Tumor cell heterogeneity: impact on
mechanisms of therapeutic drug resistance. Int J Radiat Oncol Biol Phys
1997, 39(4):789–795.
3. Balunas MJ, Kinghorn AD: Drug discovery from medicinal plants. Life Sci
2005, 78(5):431–441.
4. Pezzuto JM: Plant-derived anticancer agents. Biochem Pharmacol 1997,
53(2):121–133.
5. Abdel-Hamid NM, Nazmy MH, Mahmoud AW, Fawzy MA, Youssof M: A
survey on herbal management of hepatocellular carcinoma. World J
Hepatol 2011, 3(7):175–183.
6. Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T:
Dietary fibre, whole grains, and risk of colorectal cancer: systematic
review and dose-response meta-analysis of prospective studies.
BMJ 2011, 343:d6617.
7. Steinmetz KA, Potter JD: Vegetables, fruit, and cancer prevention: a
review. J Am Diet Assoc 1996, 96(10):1027–1039.
8. Van Duyn MA, Pivonka E: Overview of the health benefits of fruit and
vegetable consumption for the dietetics professional: selected literature.
J Am Diet Assoc 2000, 100(12):1511–1521.
9. Aggarwal BB, Van Kuiken ME, Iyer LH, Harikumar KB, Sung B: Molecular
targets of nutraceuticals derived from dietary spices: potential role in
suppression of inflammation and tumorigenesis. Exp Biol Med (Maywood)
2009, 234(8):825–849.
10. Haque N, Salma U, Nurunnabi TR, Haque AK, Mukti IJ, Pervin S, Nahar R:
Lifestyle related causes of cancer and chemoprevention through
phytonutrients. Pak J Biol Sci 2010, 13(19):916–926.
11. Guilford JM, Pezzuto JM: Natural products as inhibitors of carcinogenesis.
Expert Opin Investig Drugs 2008, 17(9):1341–1352.
12. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev
Cancer 2003, 3(10):768–780.
13. Gupta SC, Kim JH, Prasad S, Aggarwal BB: Regulation of survival,
proliferation, invasion, angiogenesis, and metastasis of tumor cells
through modulation of inflammatory pathways by nutraceuticals. Cancer
Metastasis Rev 2010, 29(3):405–434.
14. Sung B, Prasad S, Yadav VR, Aggarwal BB: Cancer cell signaling pathways
targeted by spice-derived nutraceuticals. Nutr Cancer 2012, 64(2):173–197.
Al-Daghri et al. BMC Complementary and Alternative Medicine 2012, 12:202 Page 8 of 8
http://www.biomedcentral.com/1472-6882/12/20215. Jagetia GC, Aggarwal BB: "Spicing up" of the immune system by
curcumin. J Clin Immunol 2007, 27(1):19–35.
16. Butler MS: Natural products to drugs: natural product-derived
compounds in clinical trials. Nat Prod Rep 2008, 25(3):475–516.
17. Dhillon RAW N, Abbruzzese JL, Hong DS, Camacho LH, Li L, Braiteh F,
Kurzrock R: Phase II clinical trial of curcumin in patients with advanced
pancreatic cancer. J Clin Oncol (Meeting Abstracts) 2006, 24(18S):14151.
18. Sashidhara KV, White KN, Crews P: A selective account of effective
paradigms and significant outcomes in the discovery of inspirational
marine natural products. J Nat Prod 2009, 72(3):588–603.
19. Ulbricht C, Basch E, Burke D, Cheung L, Ernst E, Giese N, Foppa I,
Hammerness P, Hashmi S, Kuo G, et al: Fenugreek (Trigonella
foenum-graecum L. Leguminosae): an evidence-based systematic
review by the natural standard research collaboration. J Herb
Pharmacother 2007, 7(3-4):143–177.
20. Prabhakar PK, Doble M: Mechanism of action of natural products used in
the treatment of diabetes mellitus. Chin J Integr Med 2011, 17(8):563–574.
21. Haque N, Salma U, Nurunnabi TR, Uddin MJ, Jahangir MF, Islam SM,
Kamruzzaman M: Management of type 2 diabetes mellitus by lifestyle,
diet and medicinal plants. Pak J Biol Sci 2011, 14(1):13–24.
22. Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M:
The efficacy and safety of herbal medicines used in the treatment
of hyperlipidemia; a systematic review. Curr Pharm Des 2010,
16(26):2935–2947.
23. Sirtori CR, Galli C, Anderson JW, Sirtori E, Arnoldi A: Functional foods for
dyslipidaemia and cardiovascular risk prevention. Nutr Res Rev 2009,
22(2):244–261.
24. Dwivedi S, Aggarwal A: Indigenous drugs in ischemic heart disease in
patients with diabetes. J Altern Complement Med 2009, 15(11):1215–1221.
25. Shabbeer S, Sobolewski M, Anchoori RK, Kachhap S, Hidalgo M,
Jimeno A, Davidson N, Carducci MA, Khan SR: Fenugreek: a naturally
occurring edible spice as an anticancer agent. Cancer Biol Ther 2009,
8(3):272–278.
26. Raju J, Patlolla JM, Swamy MV, Rao CV: Diosgenin, a steroid saponin of
Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced
aberrant crypt foci formation in F344 rats and induces apoptosis in
HT-29 human colon cancer cells. Cancer Epidemiol Biomarkers Prev 2004,
13(8):1392–1398.
27. Amin A, Alkaabi A, Al-Falasi S, Daoud SA: Chemopreventive activities of
Trigonella foenum graecum (Fenugreek) against breast cancer. Cell Biol
Int 2005, 29(8):687–694.
28. Bin-Hafeez B, Haque R, Parvez S, Pandey S, Sayeed I, Raisuddin S:
Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.)
extract in mice. Int Immunopharmacol 2003, 3(2):257–265.
29. Corbiere C, Liagre B, Bianchi A, Bordji K, Dauca M, Netter P, Beneytout JL:
Different contribution of apoptosis to the antiproliferative effects of
diosgenin and other plant steroids, hecogenin and tigogenin, on human
1547 osteosarcoma cells. Int J Oncol 2003, 22(4):899–905.
30. Liu MJ, Wang Z, Ju Y, Wong RN, Wu QY: Diosgenin induces cell cycle
arrest and apoptosis in human leukemia K562 cells with the disruption
of Ca2+ homeostasis. Cancer Chemother Pharmacol 2005, 55(1):79–90.
31. Srinivasan S, Koduru S, Kumar R, Venguswamy G, Kyprianou N,
Damodaran C: Diosgenin targets Akt-mediated prosurvival signaling
in human breast cancer cells. Int J Cancer 2009, 125(4):961–967.
32. Khoja KK, Shaf G, Hasan TN, Syed NA, Al-Khalifa AS, Al-Assaf AH, Alshatwi
AA: Fenugreek, a naturally occurring edible spice, kills MCF-7 human
breast cancer cells via an apoptotic pathway. Asian Pac J Cancer Prev
2011, 12(12):3299–3304.
33. Li F, Fernandez PP, Rajendran P, Hui KM, Sethi G: Diosgenin, a steroidal
saponin, inhibits STAT3 signaling pathway leading to suppression of
proliferation and chemosensitization of human hepatocellular carcinoma
cells. Cancer Lett 2010, 292(2):197–207.
34. Chen PS, Shih YW, Huang HC, Cheng HW: Diosgenin, a steroidal saponin,
inhibits migration and invasion of human prostate cancer PC-3 cells by
reducing matrix metalloproteinases expression. PLoS One 2011,
6(5):e20164.
35. Varjas T, Nowrasteh G, Budan F, Horvath G, Cseh J, Gyongyi Z, Makai S,
Ember I: The effect of fenugreek on the gene expression of arachidonic
acid metabolizing enzymes. Phytother Res 2011, 25(2):221–227.
36. Shishodia S, Aggarwal BB: Diosgenin inhibits osteoclastogenesis, invasion,
and proliferation through the downregulation of Akt, I kappa B kinaseactivation and NF-kappa B-regulated gene expression. Oncogene 2006,
25(10):1463–1473.
37. Klionsky DJ, Emr SD: Autophagy as a regulated pathway of cellular
degradation. Science 2000, 290(5497):1717–1721.
38. Chen N, Debnath J: Autophagy and tumorigenesis. FEBS Lett 2010,
584(7):1427–1435.
39. Clarke PG: Developmental cell death: morphological diversity and
multiple mechanisms. Anat Embryol (Berl) 1990, 181(3):195–213.
40. Vicencio JM, Galluzzi L, Tajeddine N, Ortiz C, Criollo A, Tasdemir E, Morselli E,
Ben Younes A, Maiuri MC, Lavandero S, et al: Senescence, apoptosis or
autophagy? When a damaged cell must decide its path--a mini-review.
Gerontology 2008, 54(2):92–99.
41. Levine B, Kroemer G: Autophagy in the pathogenesis of disease. Cell 2008,
132(1):27–42.
42. Mathew R, Karantza-Wadsworth V, White E: Role of autophagy in cancer.
Nat Rev Cancer 2007, 7(12):961–967.
43. Botti J, Djavaheri-Mergny M, Pilatte Y, Codogno P: Autophagy signaling
and the cogwheels of cancer. Autophagy 2006, 2(2):67–73.
44. Tanida I, Ueno T, Kominami E: LC3 conjugation system in mammalian
autophagy. Int J Biochem Cell Biol 2004, 36(12):2503–2518.
45. Abe A, Yamada H, Moriya S, Miyazawa K: The beta-carboline alkaloid
harmol induces cell death via autophagy but not apoptosis in
human non-small cell lung cancer A549 cells. Biol Pharm Bull 2011,
34(8):1264–1272.
46. Hannigan AM, Gorski SM: Macroautophagy: the key ingredient to a
healthy diet? Autophagy 2009, 5(2):140–151.
47. Hu YL, Delay M, Jahangiri A, Molinaro AM, Rose SD, Carbonell WS, Aghi MK:
Hypoxia-induced autophagy promotes tumor cell survival and
adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 2012,
72(7):1773–1783.
48. Malkinson AM, Beer DS: Pharmacologic and genetic studies on the
modulatory effects of butylated hydroxytoluene on mouse lung
adenoma formation. J Natl Cancer Inst 1984, 73(4):925–933.
49. Kundu JK, Na HK, Surh YJ: Ginger-derived phenolic substances with
cancer preventive and therapeutic potential. Forum Nutr 2009,
61:182–192.
50. Deb J, Dibra H, Shan S, Rajan S, Manneh J, Kankipati CS, Perry CJ, Nicholl ID:
Activity of aspirin analogues and vanillin in a human colorectal cancer
cell line. Oncol Rep 2011, 26(3):557–565.
51. Vidhya N, Devaraj SN: Induction of apoptosis by eugenol in human breast
cancer cells. Indian J Exp Biol 2011, 49(11):871–878.
52. Jaganathan SK, Mazumdar A, Mondhe D, Mandal M: Apoptotic effect of
eugenol in human colon cancer cell lines. Cell Biol Int 2011, 35(6):607–615.
53. Manikandan P, Murugan RS, Priyadarsini RV, Vinothini G, Nagini S: Eugenol
induces apoptosis and inhibits invasion and angiogenesis in a rat
model of gastric carcinogenesis induced by MNNG. Life Sci 2010,
86(25–26):936–941.
54. Sakr SA, Abo-El-Yazid SM: Effect of fenugreek seed extract on
adriamycin-induced hepatotoxicity and oxidative stress in albino rats.
Toxicol Ind Health 0748233711425076 2011, doi:10.1177/0748233711425076.
55. Sushma N, Devasena T: Aqueous extract of Trigonella foenum graecum
(fenugreek) prevents cypermethrin-induced hepatotoxicity and
nephrotoxicity. Hum Exp Toxicol 2010, 29(4):311–319.
56. Muraki E, Hayashi Y, Chiba H, Tsunoda N, Kasono K: Dose-dependent
effects, safety and tolerability of fenugreek in diet-induced metabolic
disorders in rats. Lipids Health Dis 2011, 10:240.
doi:10.1186/1472-6882-12-202
Cite this article as: Al-Daghri et al.: Fenugreek extract as an inducer of
cellular death via autophagy in human T lymphoma Jurkat cells. BMC
Complementary and Alternative Medicine 2012 12:202.
